Market Place
Sourcing Support
Virios Therapeutics Announces Second Quarter 2024 Financial Results
08 Aug 2024 //
GLOBENEWSWIRE
Hyloris Announces Positive Clinical Study Results for Valacyclovir
26 Dec 2023 //
GLOBENEWSWIRE
GSK to cut US prices for Advair, Valtrex and Lamictal
23 Dec 2023 //
REUTERS
Virios Announces Data Demonstrating Improvement in Multiple Long-COVID Symptoms
17 Jul 2023 //
GLOBENEWSWIRE
Virios doses first subject in long Covid antiviral trial
16 Aug 2022 //
CLINICALTRIALSARENA
Virio Announces Dosing of First Patient in IMC-2 Long-COVID Treatment Trial
15 Aug 2022 //
BUSINESSWIRE
Candel Completes PIII Enrollment of CAN-2409+Valacyclovir in prostate cancer
07 Sep 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.